Browse by Material Type
![]() | Up a level |
central nervous system
BTG International Ltd. (2011) Treatment of neurodegenerative conditions. JP2011144195.
BTG International Ltd. (2011) Treatment of neurodegenerative conditions. EP2324828 (A1).
cytokines
BTG International Ltd (2009) Structured phospholipids. US2009/0036410 A1.
multiple sclerosis
BTG International Ltd. (2011) Treatment of neurodegenerative conditions. JP2011144195.
BTG International Ltd (2009) Structured phospholipids. US2009/0036410 A1.
BTG International Ltd. (2011) Treatment of neurodegenerative conditions. EP2324828 (A1).
neurodegeneration
BTG International Ltd. (2011) Treatment of neurodegenerative conditions. JP2011144195.
BTG International Ltd. (2011) Treatment of neurodegenerative conditions. EP2324828 (A1).
polyunsaturated fatty acids
BTG International Ltd (2010) Treatment of neurodegenerative conditions. US2010/0113810 A1.
structured phospholipids
BTG International Ltd (2009) Structured phospholipids. US2009/0036410 A1.
treatment of multiple sclerosis
BTG International Ltd (2010) Treatment of neurodegenerative conditions. US2010/0113810 A1.



